The effect of immunotoxins directed against CD80 and CD86 on primary T-cell alloresponses

Tissue Antigens

Volumn 52, Issue 3, 1998, Pages 270-274

  Otten, H G ^a   Vooijs, W C ^a   Van Der Gouw, L ^a   De Boer, M ^b   De Gast, G C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Pangenetics   (Netherlands)

Author keywords

CD80; CD86; Human; Immunotoxin

Indexed keywords

B7 ANTIGEN; CD86 ANTIGEN; GELONIN; IMMUNOTOXIN;

ALLOIMMUNITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ARTICLE; CELL LINE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MIXED LYMPHOCYTE CULTURE; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 0031668903     PISSN: 00012815     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0039.1998.tb03042.x     Document Type: Article

References (18)

1. D'Elios MM, Josien R, Manghetti M et al. Predominant Th1 cell infiltration in acute rejection episodes of human kidney grafts. Kidney Int 1997: 51: 1876-84.
2. Bluestone JA. Costimulation and its role in organ transplantation. Clin Transpl 1996: 10: 104-9.
3. Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol 1996: 14: 233-58.
4. Jenkins MK, Johnson JG. Molecules involved in T-cell costimulation. Curr Opin Immunol 1993: 5: 361-7.
5. Van Dijk AMC, Otten HG, Vercauteren SM et al. Human B7-1 is more efficient than B7-2 in providing costimulation for allo-antigen specific T-cells. Eur J Immunol 1996: 26: 2275-8.
6. Ellis JH, Burden MN, Vinogradov DV, Linge C, Crowe JS. Interactions of CD80 and CD86 with CD28 and CTLA4. J Immunol 1996: 156: 2700-9.
7. Otten HG, Bor B, Ververs C, Verdonck LF, De Boer M, De Gast GC. Allo-antigen specific T cell anergy induced by human keratinocytes is abrogated upon loss of cell-cell contact. Immunology 1996: 88: 214-9.
8. Lanier LL, O'Fallon S, Somoza C et al. CD80 (B7) and CD86 (B70) provide similar costimulatory signals for T cell proliferation, cytokine production, and generation of CTL. J Immunol 1995: 154: 97-105.
9. Van Gool SW, De Boer M, Ceuppens JL. CD28 ligation by monoclonal antibodies or B7/BB1 provides an accessory signal for the cyclosporin A-resistant generation of cytotoxic T cell activity. J Immunol 1993: 150: 3254-63.
10. Pearson TC, Alexander DZ, Winn KJ, Linsley PS, Lowry RP, Larsen CP. Transplantation tolerance induced by CTLA4-Ig. Transplantation 1994: 57: 1701-6.
11. Linsley PS, Wallace PM, Johnson J et al. Immunosuppression in vivo by a soluble form of the CTLA-4 T cell activation molecule. Science 1992: 257: 792-5.
12. Kirk AD, Harlan DMN, Armstrong NN et al. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 1997: 94: 8789-94.
13. Vooijs WC, Otten HG, Van Dijk AJG et al. B7-1 as target for immunotoxin therapy in Hodgkin's disease. Br J Cancer 1997: 76: 1163-9.
14. Mujoo K, Cheung L, Murray JL, Rosenblum MG. Pharmacokinetics, tissue distribution and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin. Cancer Immunol Immunother 1995: 40: 339-45.
15. Stirpe F, Olsnes S, Pihl A. Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. A. J Biol Chem 1980: 255: 6847-53.
16. Rock KL, Rothstein L, Gamble S, Fleischacker C. Characterization of antigen-presenting cells that present exogenous antigens with Class-I molecules. J Immunol 1993: 150: 438-46.
17. Reimann KA, Goldmacher VS, Lambert JL et al. In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. J Clin Invest 1988: 82: 129-39.
18. Magellan AD, Starling GC, Williams LA, Hock BD, Hart DN. Activation of human peripheral blood dendritic cells induces the CD86 costimulatory molecule. Eur J Immunol 1995: 25: 2064-8.